2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Tsiporah B. Shore, MD, associate director of the Blood and Bone Marrow Transplant Program of Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses stem cell transplantation in patients with hematologic malignancies and are of ethnic populations.
Tsiporah B. Shore, MD, associate director of the Blood and Bone Marrow Transplant Program of Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses stem cell transplantation in patients of multi-ethnic populations who have hematologic malignancies.
Stem cell transplant is a very important procedure that should be available for all patients, Shore explains. However, for those who are in multi-ethnic populations, physicians should accommodate many groups of patients. There are very limited donors for these patient populations, but something must be done to allow patients to have this therapeutic option.
Additionally, a new method is the haplo-cord transplant and haploidentical transplant, which largely help to find transplants for a wider variety of patients.